Skip to content

A few things to know about Pap smears & cervical cancer

Published by Connealy, MD on July 22, 2024

gynecologist-with-patient-in-the-office-2023-11-27-04-57-12-utc

A Pap smear, also known as a Pap test, is a medical procedure used to screen for cervical cancer in women. It is named after Georgios Papanikolaou, the physician who determined it could be used to detect early signs of cervical cancer. 

During the test, cells are gently scraped from the cervix and examined under a microscope. The primary purpose of a Pap smear is to detect precancerous or cancerous cells on the cervix. It can also identify changes in cervical cells that might suggest the presence of human papillomavirus (HPV), a common sexually transmitted infection that can lead to cervical cancer. 

Normal cells: Represent healthy cervical tissue. Pap smears aim to identify this baseline to ensure no abnormal changes are present.

Dysplasia: Refers to precancerous changes in cervical cells. The presence of dysplastic cells suggests abnormal changes that may lead to cancer if untreated.

Cancer Cells: Indicate the presence of invasive cervical cancer. Detecting cancer cells early through a Pap smear allows for timely treatment to manage and potentially cure the disease.

HPV and Cervical Cancer

There is a longstanding theory that HPV is linked to cancer. However, research suggests that a suppressed immune system may actually play a significant role. This is especially interesting because hormones including estrogen and cortisol suppress immunity, and by this mechanism, can increase the risk of cancer. So, rather than HPV directly causing cancer, this theory suggests that the virus exploits an already weakened immune system, allowing cancerous changes to take hold more easily.

The immune system constantly monitors and eliminates abnormal cells. When the immune system is compromised, its ability to perform this function is reduced, increasing the risk of cancer.

In fact, a robust immune response can often clear HPV infections. In individuals with weakened immunity, high cortisol, and high estrogen relative to progesterone, HPV infections may persist longer, increasing the likelihood of cellular changes that lead to cancer. This is because cortisol and estrogen are two potential immunosuppressive hormones. 

So what is the role of estrogen and cortisol in cervical cancer?

Estrogen and Cervical Cancer

Cervical cells contain estrogen receptors. When estrogen binds to these receptors, it promotes the growth and division of cervical epithelial cells. This increased proliferation can enhance the likelihood of cellular mutations and cancerous transformations.

Estrogen affects the activity of T-cells, which are crucial for adaptive immunity. High levels of estrogen can reduce the proliferation of cytotoxic T-cells, which are responsible for killing virus-infected cells and cancer cells.

Cortisol and Cervical Cancer

Cortisol, often referred to as the stress hormone, significantly impacts the body’s response to stress and has notable immune-suppressive effects, particularly in the context of cervical cancer. Elevated cortisol levels can inhibit the activity and proliferation of natural killer (NK) cells and cytotoxic T-cells, which are essential for identifying and destroying cancer cells and cells infected by viruses, including HPV. This suppression of immune function can allow cervical cancer to progress unchecked by the body’s natural defense mechanisms.

Histamine and Cervical Cancer

A study conducted in 2020 also challenges the common belief that HPV is the primary cause of cervical cancer, suggesting instead that estrogen plays a bigger role. The study found that histamine, a substance involved in immune responses, can increase the activity of estrogen receptors in cervical cancer cells, making the environment more “estrogenic” and promoting cancer growth. Interestingly, the study showed that a natural compound called apigenin, which acts as both an antihistamine and an estrogen blocker, was effective in treating cervical cancer. This supports the idea that both histamine and estrogen are crucial in driving cancer and that targeting them together might offer a more effective treatment strategy.

Other potential drivers of cervical cancer:

  • Long-term Use of Oral Contraceptives: Prolonged use of oral contraceptives has been associated with an increased risk of cervical cancer.
  • Exposure to Diethylstilbestrol (DES): Women whose mothers took DES, a synthetic estrogen, during pregnancy to prevent miscarriage, are at an increased risk of developing clear-cell adenocarcinoma of the cervix and vagina.
  • Chronic Inflammation: Conditions that cause chronic inflammation of the cervix, such as chronic cervicitis, can increase the risk of cancerous changes.
  • Early Sexual Activity and Multiple Sexual Partners: From the perspective of German New Medicine, early sexual activity and multiple partners can result in unresolved emotional trauma, particularly related to sexual and relational conflicts. This trauma is believed to manifest physically as cervical cancer, with the disease representing the body’s response to these deep-seated emotional traumas. 
  • Poor Nutrition: A diet high in polyunsaturated fats and low in essential nutrients can disrupt hormonal balance and metabolic processes, potentially contributing to cervical cancer.

Cervical cancer is not just about HPV; it requires a conducive cellular environment for cancer to develop. It’s crucial that we delve into all potential causal factors, not just the commonly recognized ones.

The research referenced in this post is credited to articles written by Georgi Dinkov. You can find his blog at haduit.me (http://haidut.me) and support his product through IdeaLabs.

Get Started Now!

Optimize your health with Connealy, MD